AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $147,000 | -67.0% | 15,608 | -57.4% | 0.00% | -100.0% |
| Q4 2019 | $446,000 | +284.5% | 36,654 | +266.5% | 0.00% | – |
| Q3 2019 | $116,000 | +2.7% | 10,000 | -11.4% | 0.00% | – |
| Q2 2019 | $113,000 | -83.2% | 11,284 | -74.6% | 0.00% | -100.0% |
| Q4 2018 | $673,000 | +69.5% | 44,345 | +125.1% | 0.00% | 0.0% |
| Q1 2018 | $397,000 | +146.6% | 19,700 | +62.6% | 0.00% | – |
| Q4 2017 | $161,000 | -22.6% | 12,115 | +7.5% | 0.00% | -100.0% |
| Q3 2017 | $208,000 | -48.4% | 11,273 | -36.8% | 0.00% | -50.0% |
| Q1 2017 | $403,000 | +52.7% | 17,851 | +65.7% | 0.00% | +100.0% |
| Q3 2016 | $264,000 | -7.7% | 10,776 | -9.9% | 0.00% | 0.0% |
| Q2 2016 | $286,000 | -5.0% | 11,955 | -7.1% | 0.00% | -50.0% |
| Q1 2016 | $301,000 | -76.8% | 12,874 | -31.6% | 0.00% | -75.0% |
| Q2 2015 | $1,300,000 | +101.2% | 18,826 | +59.1% | 0.01% | +60.0% |
| Q1 2015 | $646,000 | -60.2% | 11,834 | -76.8% | 0.01% | -70.6% |
| Q3 2014 | $1,624,000 | – | 50,902 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |